Inactive Instrument

20/20 GeneSystems Inc. Stock

Equities

Duration

Period

Style

20/20 GeneSystems, Inc. announced that it expects to receive $5.000002 million in funding	May. 05	CI
20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	22-08-14	CI
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	21-09-28	CI
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	16-02-03	CI
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	16-01-27	CI
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	16-01-13	CI
20/20 GeneSystems, Inc. announced that it expects to receive $4 million in funding from Ping An Ventures.	14-10-30	CI
20/20 GeneSystems Inc. announced that it has received funding from BHC Center Of Financial & Investment Business LLC	14-08-17	CI

Managers	Title	Age	Since
Jonathan Cohen CEO	Chief Executive Officer	-	07-12-31
Nora Li PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Richard Cohen BRD	Director/Board Member	73	15-12-31
Jonathan Cohen CEO	Chief Executive Officer	-	07-12-31
John Compton BRD	Director/Board Member	-	-

Sector